Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

This study has been completed.

Study NCT00050817 Information provided by Sanofi-Aventis

First Received: December 20, 2002 Last Updated: March 24, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2005
Estimated Primary Completion Date:	No date given